|
DE102006042143A1
(de)
*
|
2006-09-08 |
2008-03-27 |
Bayer Healthcare Aktiengesellschaft |
Neue substituierte Bipyridin-Derivate und ihre Verwendung
|
|
DE102006056740A1
(de)
*
|
2006-12-01 |
2008-06-05 |
Bayer Healthcare Ag |
Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung
|
|
DE102006056739A1
(de)
*
|
2006-12-01 |
2008-06-05 |
Bayer Healthcare Ag |
Substituierte 4-Amino-3,5-dicyano-2-thiopyridine und ihre Verwendung
|
|
DE102007035367A1
(de)
|
2007-07-27 |
2009-01-29 |
Bayer Healthcare Ag |
Substituierte Aryloxazole und ihre Verwendung
|
|
DE102007036076A1
(de)
|
2007-08-01 |
2009-02-05 |
Bayer Healthcare Aktiengesellschaft |
Dipeptoid-Produgs und ihre Verwendung
|
|
DE102007061764A1
(de)
*
|
2007-12-20 |
2009-06-25 |
Bayer Healthcare Ag |
Anellierte Cyanopyridine und ihre Verwendung
|
|
DE102007061763A1
(de)
*
|
2007-12-20 |
2009-06-25 |
Bayer Healthcare Ag |
Substituierte azabicyclische Verbindungen und ihre Verwendung
|
|
US8343966B2
(en)
*
|
2008-01-11 |
2013-01-01 |
Novartis Ag |
Organic compounds
|
|
DE102008013587A1
(de)
*
|
2008-03-11 |
2009-09-17 |
Bayer Schering Pharma Aktiengesellschaft |
Heteroaryl-substituierte Dicyanopyridine und ihre Verwendung
|
|
US8791146B2
(en)
*
|
2008-05-29 |
2014-07-29 |
Bayer Intellectual Property Gmbh |
2-alkoxy-substituted dicyanopyridines and their use
|
|
WO2010007756A1
(ja)
*
|
2008-07-14 |
2010-01-21 |
塩野義製薬株式会社 |
Ｔｔｋ阻害作用を有するピリジン誘導体
|
|
DE102008062567A1
(de)
|
2008-12-16 |
2010-06-17 |
Bayer Schering Pharma Aktiengesellschaft |
Dipeptoid-Prodrugs und ihre Verwendung
|
|
DE102009006602A1
(de)
*
|
2009-01-29 |
2010-08-05 |
Bayer Schering Pharma Aktiengesellschaft |
Alkylamino-substituierte Dicyanopyridine und deren Aminosäureester-Prodrugs
|
|
JP2012529535A
(ja)
|
2009-06-12 |
2012-11-22 |
ブリストル−マイヤーズ スクイブ カンパニー |
キナーゼモジュレーターとして有用なニコチンアミド化合物
|
|
CA2811989A1
(en)
|
2010-04-23 |
2011-10-27 |
Kineta, Inc. |
Diarylpyridine anti-viral compounds
|
|
CA2800618C
(en)
*
|
2010-05-26 |
2018-08-28 |
Sunovion Pharmaceuticals Inc. |
Heteroaryl compounds and methods of use thereof
|
|
DE102010030688A1
(de)
|
2010-06-30 |
2012-01-05 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte Dicyanopyridine und ihre Verwendung
|
|
US20120058983A1
(en)
|
2010-09-02 |
2012-03-08 |
Bayer Pharma Aktiengesellschaft |
Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
|
|
WO2014034898A1
(ja)
*
|
2012-08-30 |
2014-03-06 |
日本新薬株式会社 |
ピリジン誘導体及び医薬
|
|
CN105324376B
(zh)
|
2013-06-27 |
2017-06-23 |
辉瑞大药厂 |
杂芳族化合物及其作为多巴胺d1配体的用途
|
|
EP3116513A4
(en)
*
|
2014-03-14 |
2017-10-25 |
Andes Biotechnologies S.A. |
Pharmaceutical compositions comprising rna and use for treating cancer
|
|
GB201514021D0
(en)
|
2015-08-07 |
2015-09-23 |
Arner Elias Set Jeno |
Novel Pyridines and their use in the treatment of cancer
|
|
ES2846833T3
(es)
|
2016-07-18 |
2021-07-29 |
Janssen Pharmaceutica Nv |
Ligandos de obtención de imágenes de tau por PET
|
|
MX2019009356A
(es)
|
2017-02-07 |
2019-09-19 |
Oblique Therapeutics Ab |
Sulfinilpiridinas y su uso en el tratamiento del cancer.
|
|
EP3580203A1
(en)
|
2017-02-07 |
2019-12-18 |
Oblique Therapeutics AB |
Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer
|
|
KR20190115013A
(ko)
|
2017-02-07 |
2019-10-10 |
오블리크 세러퓨틱스 에이비 |
헤테로아릴설포닐-치환된 피리딘 및 암의 치료에서 이의 용도
|
|
KR20190115012A
(ko)
|
2017-02-07 |
2019-10-10 |
오블리크 세러퓨틱스 에이비 |
헤테로사이클릴설포닐-치환된 피리딘 및 암의 치료에서 이의 용도
|